Spandana Competitors
| SPANDANA | 450.85 25.50 5.35% |
Spandana |
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Spandana Sphoorty's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Spandana Sphoorty Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Spandana Sphoorty and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Spandana and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Spandana Sphoorty does not affect the price movement of the other competitor.
| 0.58 | -0.73 | 0.56 | 0.48 | 0.26 | BETA | ||
| 0.58 | -0.69 | 0.84 | 0.85 | 0.44 | ASTERDM | ||
| -0.73 | -0.69 | -0.68 | -0.59 | -0.33 | AKUMS | ||
| 0.56 | 0.84 | -0.68 | 0.88 | 0.61 | MAXHEALTH | ||
| 0.48 | 0.85 | -0.59 | 0.88 | 0.71 | ASALCBR | ||
| 0.26 | 0.44 | -0.33 | 0.61 | 0.71 | SDBL | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Spandana Stock performing well and Spandana Sphoorty Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spandana Sphoorty's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BETA | 2.49 | 0.39 | 0.13 | 0.55 | 2.50 | 7.11 | 14.13 | |||
| ASTERDM | 1.33 | 0.37 | 0.22 | (2.83) | 1.22 | 3.08 | 12.82 | |||
| AKUMS | 2.44 | (0.40) | 0.00 | (0.81) | 0.00 | 4.99 | 14.55 | |||
| MAXHEALTH | 1.67 | 0.41 | 0.20 | 15.51 | 1.61 | 3.51 | 9.33 | |||
| ASALCBR | 1.98 | 0.37 | 0.13 | 1.10 | 2.30 | 5.68 | 12.47 | |||
| SDBL | 1.95 | 0.07 | 0.02 | 0.43 | 2.16 | 5.47 | 11.74 |
Cross Equities Net Income Analysis
Compare Spandana Sphoorty and related stocks such as Beta Drugs, Aster DM Healthcare, and Akums Drugs Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTERDM | 917.8 M | 917.8 M | 917.8 M | 1.8 B | 1.3 B | (590.1 M) | 2 B | 2.7 B | 3.3 B | 2.8 B | 1.5 B | 5.3 B | 4.2 B | 1.3 B | 1.5 B | 2.4 B |
| MAXHEALTH | (646.5 M) | (646.5 M) | (646.5 M) | (646.5 M) | (381.4 M) | (226.1 M) | 90.5 M | (287.3 M) | (30.1 M) | 953.4 M | (1.4 B) | 6.1 B | 11 B | 10.6 B | 12.2 B | 12.8 B |
| ASALCBR | 12 M | 25.9 M | 33.1 M | 58.4 M | 123.3 M | 142.9 M | 173.8 M | 251.9 M | 302.6 M | 493.4 M | 579.6 M | 608.1 M | 415.6 M | 506.2 M | 582.2 M | 611.3 M |
| SDBL | (5.3 M) | 152.4 M | 178 M | 203 M | 161.7 M | 133.8 M | 139.3 M | 252.3 M | 197.4 M | 150.2 M | (380.7 M) | (98.4 M) | 603 M | 865 M | 994.7 M | 1 B |
Spandana Sphoorty and related stocks such as Beta Drugs, Aster DM Healthcare, and Akums Drugs Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Spandana Sphoorty financial statement analysis. It represents the amount of money remaining after all of Spandana Sphoorty Financial operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Spandana Sphoorty Competitive Analysis
The better you understand Spandana Sphoorty competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Spandana Sphoorty's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Spandana Sphoorty's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Spandana Sphoorty Competition Performance Charts
Five steps to successful analysis of Spandana Sphoorty Competition
Spandana Sphoorty's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Spandana Sphoorty in relation to its competition. Spandana Sphoorty's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Spandana Sphoorty in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Spandana Sphoorty's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Spandana Sphoorty, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Spandana Sphoorty position
In addition to having Spandana Sphoorty in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Agency Mbs ETFs Thematic Idea Now
Agency Mbs ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Agency Mbs ETFs theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agency Mbs ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Spandana Stock
Spandana Sphoorty financial ratios help investors to determine whether Spandana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spandana with respect to the benefits of owning Spandana Sphoorty security.